US EditionZapata-Gomez Succeeds Holstein As Biontech CFO, BMS’s Leung Retiring As General Counsel
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Zapata-Gomez Succeeds Holstein As Biontech CFO, BMS’s Leung Retiring As General Counsel
ARTICLE Plus: Updates from Enara, Paq, Priothera, Eccogene By Paul Bonanos, Director of Biopharma Intelligence, and Jeff Cranmer, Executive Editor and Head of Daily Global intelligence May 9, 2025 1:28 AM UTC Biontech SE (NASDAQ:BNTX) named Ramón Zapata-Gomez CFO, succeeding the retiring Jens Holstein on July 1. Since 2022, Zapata-Gomez has been CFO of The Novartis Biomedical Research unit of Novartis AG (SIX:NOVN; NYSE:NVS). Prior to that pos…
Bristol Myers Squibb appoints Cari Gallman as executive vice president, general counsel and chief policy officer - Pharmafile
Global biopharma company, Bristol Myers Squibb, has announced the appointment of Cari Gallman as executive vice president, general counsel and chief policy officer. She succeeds Sandra Leung, who has retired after spending 33 years at the company. Gallman has extensive leadership experience in pharmaceutical law and compliance, and in her new role she will lead […] The post Bristol Myers Squibb appoints Cari Gallman as executive vice president, …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
